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Abstract The effects of heparin on trypsin have recently been
demonstrated to involve inhibition of catalytic activity and
degradation of the enzyme by means of an oxidative mechanism.
The possibility that K-phenyl N-tert-butylnitrone protects
heparin-induced radical formation on trypsin was investigated
by measuring amidolytic activity and changes in the structure of
trypsin in the presence of heparin with and without K-phenyl
N-tert-butylnitrone. The results show that K-phenyl N-tert-butyl-
nitrone does not only prevent, but it even significantly enhances
effects of heparin on the enzyme. This is due to the unique
property of K-phenyl N-tert-butylnitrone, independently of spin-
trapping capacity, to modify the trypsin structure by binding
irreversibly to the catalytic triad, at sites distinct from those to
which heparin binds.
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1. Introduction
In recent years, many scienti¢c reports have dealt with the
role of various reactive oxygen species in the etiology of in-
£ammatory and degenerative pathologies a¡ecting various tis-
sues and organs. A general consensus is emerging that the
generation of free radicals and consequent oxidative stress
represent the molecular mechanism underlying both age-de-
pendent degenerative processes [1] and more severe conditions
such as stroke, Alzheimer’s disease, diabetes and cancer [1^5].
Much e¡ort has thus been spent in order to characterize the
nature and extent of the oxidative process occurring in di¡er-
ent conditions and to identify possible anti-oxidative agents to
be tested both in vitro and in vivo for ameliorating oxidative
damage. Among the various anti-oxidants tested [2^4,6^9],
spin-trapping agents such as K-phenyl N-tert-butylnitrone
(PBN) have been demonstrated to be e¡ective both in in vitro
systems and in experimental in vivo models in reducing and
preventing tissue alterations due to radical-induced oxidative
stress [4,6,9].
We recently demonstrated that heparin, a highly negatively
charged glycosaminoglycan employed as anti-thrombotic and
anti-coagulative agent in clinical practice, binds to various
proteins in a rapid and speci¢c manner followed by signi¢cant
structural and functional alterations of the protein depending
on its nature [10^12]. This speci¢c binding has also been dem-
onstrated to trigger oxidative reactions responsible for the
most signi¢cant oxidative damage on proteins [10,11,13], par-
ticularly evident when trypsin is used as reference protein
[10,13]. The oxidative nature of the process observed in the
trypsin-heparin interaction has been further con¢rmed in re-
cent studies by the presence of radicals in the EPR spectra of
trypsin with heparin using PBN as spin-trapping agent [13].
This ¢nding prompted us to test the possibility that the oxi-
dative e¡ects of heparin are antagonized by radical spin-trap-
ping, so that the trypsin function and structure should be
preserved. For this purpose, the e¡ect of PBN, in absence
and presence of heparin, was tested on bovine trypsin by
measuring the structural and functional properties of the en-
zyme in various conditions of incubation and time of addition
of either one or both substances. Unexpectedly, results indi-
cated that not only does PBN not antagonize or prevent hep-
arin e¡ects on trypsin, but it enhances heparin-induced en-
zyme inactivation and degradation.
2. Materials and methods
Trypsin (EC 3.4.21.4, TPCK-treated, from bovine pancreas), NK-
benzoyl-DL-arginine-p-nitroanilide hydrochloride (BAPNA), PBN and
soybean trypsin inhibitor (STI) were from Sigma. Low molecular
mass heparin (5.2 kDa) from pig intestinal mucosa, with about nine
disaccharide units/molecule, was a generous gift of Prof. B. Casu, ‘G.
Ronzoni’ Institute of Chemistry and Biochemistry, Milan. Its purity
was assessed as reported previously [14]. All other chemicals were of
the highest available grade.
Solutions were made up in puri¢ed distilled water and 20 mM Na-
phosphate bu¡er (pH 6.0) with 0.15 M NaCl (PBS) ¢ltered through
0.2 Wm Millipore ¢lters. Electrospray mass analysis (ES-MS) showed
that trypsin contained only one active species. Trypsin was used at a
¢nal concentration of 0.75 mg/ml (32 WM), in the absence and pres-
ence of 25 mM PBN, with and without heparin at 36 and 360 Wg/ml
(6.9 and 69 WM, respectively). Solutions were tested both fresh and
after incubation for 2.5 h at 37‡C in a stirring bath.
Circular dichroism (CD) spectra were measured on a Jasco J-715
spectropolarimeter. Solutions of PBN (25 mM), in the absence and
presence of trypsin after incubation at 37‡C for 2.5 h, were analyzed
in a quartz cell of 0.1 cm path length and spectra were recorded in the
wavelength range of 400^320 nm. This range excluded wavelengths at
which both PBN and amino acid residues of the proteinase absorbed,
thus permitting measurement of any dichroism signal generated by the
carbon atom of PBN which had become chiral in the presence of
trypsin. Four scan spectra were recorded using a scanning velocity
of 10 nm/min. Air and water baseline values were subtracted from
each spectrum.
EPR spectra were measured at room temperature using a Bruker
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ESP 300 X-band spectrometer. Samples were analyzed in a £at quartz
cell to minimize dielectric dispersion of aqueous solvent. A modula-
tion ¢eld of 100 kHz was used with an amplitude of 1 Gauss.
The activity of trypsin in the absence (control) and presence of
heparin and PBN, both alone and together, was measured at 410 nm
on a Shimadzu UV-160 visible recording spectrophotometer as the
concentration of p-nitroaniline forming by degradation of BAPNA
at 25‡C in 50 mM Tris-HCl with 20 mM CaCl2, pH 8.3 [15]. 10 Wl
aliquots of trypsin (128 nM, ¢nal concentration), both fresh (in prog-
ress curve experiments) and incubated (drawn at 0.5 h intervals over a
period of 2.5 h), in the absence (control) and presence of PBN and
heparin, were added to the substrate (0.6 mM BAPNA) in thermo-
stated cuvettes at 25‡C. Reactions were followed by monitoring the
increase in absorbance every minute for 15 min. The reaction was
found to be linear up to 30 min. In separate progress curve experi-
ments, PBN and heparin were added to the substrate in the assay
bu¡er and the reaction was started by the addition of trypsin. In
control experiments, it was con¢rmed that neither heparin nor PBN
alone had any proteolytic activity on the substrate.
SDS-PAGE was performed according to the method of Laemmli
[16] on a 18% acrylamide gel by loading 25 Wg proteins of each sample
per lane without any prior heating or reducing treatment. Gels were
stained with Coomassie brilliant blue. In non-denaturing electropho-
resis, SDS was replaced by Triton X-100 in the running and sample
bu¡ers at ¢nal concentrations of 10 (v/v) and 5%, respectively. Sample
proteins were 50 Wg/lane.
ES-MS measurements were carried out at the Glaxo Research Lab-
oratories in Verona (Italy), using a Biotech single quadrupole VG-
Platform instrument. Analysis was performed on 300 Wg proteins of
trypsin incubated with PBN in the absence and presence of heparin,
lyophilized and redissolved in water containing 1% acetic acid. 25^50
pmol/Wl of each sample was directly injected into the ES source using
a Phoenix 20 CU pump, at a £ow rate of 10 Wl/min. The acceleration
potential was 37 V at a source temperature of 40‡C. The scanning
range was 550^120 m/z.
Statistical analyses were performed by GraphPad PRISM (version
2.0). The in£uence of the variables (PBN and heparin) on trypsin
activity was tested by two-way analysis of variance (ANOVA) and
the means between groups by non-parametric tests.
3. Results and discussion
In preliminary experiments, the e¡ects of increasing PBN
concentrations (5, 10, 15 and 25 mM) tested on trypsin after
incubation at 37‡C for 2.5 h gave activity inhibitions of 12, 21,
25 and 30%, respectively. The characteristics of PBN binding
to trypsin were investigated by following the velocity of the
reaction in the ¢rst 15 min, after either enzyme or substrate
was added to the incubation mixture to start the reaction.
This procedure can discriminate between the reversibility
and irreversibility of enzyme activity inhibition [17]. When
PBN was added to the substrate before enzyme addition,
the velocity did not change and the curves in the absence
and presence of PBN overlapped (data not shown). When
PBN was added to the enzyme before substrate addition,
the velocity decreased (Fig. 1A: slopes of curves in absence
and presence of PBN, 0.0181 and 0.0157, respectively,
P6 0.05), indicating irreversible inhibition of the enzyme
[17]. A rapid and irreversible enzyme inhibition was also
caused by heparin alone. This e¡ect was further enhanced
by PBN, reaching statistical signi¢cance at the lowest heparin
concentration (Fig. 1A: slope of curve, 0.0146, P6 0.05 for
comparisons with trypsin controls without and with 36 Wg/ml
heparin).
As shown in Fig. 1B, at each heparin concentration, PBN
was able to enhance the heparin-induced, time-dependent in-
hibition of enzyme activity. There was a signi¢cant individual
e¡ect of PBN and heparin on trypsin activity without any
interaction between the two substances (two-way ANOVA,
P = 0.0229 and P6 0.0001 for PBN and heparin e¡ects, re-
spectively). Analysis of enzyme activity made by Dixon plots
[19] with various heparin concentrations in the absence and
presence of a ¢xed PBN concentration (25 mM) (Fig. 1C) did
con¢rm that PBN and heparin behave as non-competitive
inhibitors of trypsin, causing synergistic inhibition due to
binding to di¡erent sites on the enzyme [18].
In the presence of PBN alone, the electrophoretic pattern of
trypsin turned out to be signi¢cantly altered in SDS-PAGE
(Fig. 2A, lane 2 versus lane 1), with disappearance of the main
trypsin band of about 24 kDa. When PBN was used together
with heparin, the dose-dependent pattern of trypsin fragmen-
tation due to heparin alone (lanes 3 and 5) was further wors-
ened (lanes 4 and 6). In order to exclude the possible e¡ect of
SDS in causing the structural modi¢cations of trypsin ob-
served with PBN, with and without heparin, non-denaturing
electrophoresis was performed on the same samples (Fig. 2B).
While PBN alone caused a signi¢cant change of the band
closest to the cathode, which almost completely disappeared
Fig. 1. Amidolytic activity of trypsin. E¡ects of separate and com-
bined addition of heparin and PBN. (A) Progress curves of activity
in the ¢rst 15 min reaction with fresh reactants. (B) At each time,
values of activity after 15 min reaction are reported. Each point is
the mean of three measurements made on separate occasions. Both
in (A) and (B), activity without PBN and with PBN is indicated by
empty and ¢lled symbols, respectively. Control trypsin: -a-, -b- ;
trypsin with heparin at 36 Wg/ml (E, F) and 360 Wg/ml (O, R). (C)
Dixon plots of 1/v of enzyme activity versus di¡erent heparin con-
centrations in the absence (E) and presence of a ¢xed concentration
(25 mM) of PBN (F).
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(lane 2), the addition of heparin gave rise to a marked reduc-
tion in another cathodal band, together with the appearance
of a new band closer to the anode (Fig. 2, arrows on the right)
which was due to the e¡ect of heparin alone on trypsin.
ES-MS analysis con¢rmed that trypsin underwent almost
complete fragmentation when PBN and heparin were added
together (Fig. 3). The 23 320 Da species referring to intact
trypsin, the only one visible in trypsin samples with PBN
alone (1), could no longer be detected in samples with PBN
and heparin, but was replaced by various fragments of a lower
molecular mass (2 and 3). At the highest heparin concentra-
tion, more numerous trypsin fragments were present and they
also di¡ered in molecular mass from those seen at the lowest
heparin concentration. This result ¢ts those of amidolytic ac-
tivity and electrophoretic data showing massive indiscriminate
fragmentation of the proteinase which loses activity. Mass
analysis results were strikingly di¡erent from those reported
previously on trypsin in the presence of heparin alone [13],
which showed that trypsin underwent more limited fragmen-
tation with the appearance of only two trypsin fragments in
addition of the intact trypsin species.
STI was used as a tool to explore the nature of the heparin
plus PBN interaction with the catalytic site of trypsin. If hep-
arin e¡ects were mediated by its binding to sites involving the
catalytic triad of trypsin, as previously proposed [10], and if
this property was also shared with PBN, then, prior inhibition
of the catalytic site by a known speci¢c inhibitor would be
expected to prevent or reduce heparin e¡ects, with and with-
out PBN, i.e. trypsin would undergo less or no degradation at
all. In order to test this hypothesis, STI was used at both non-
saturating (0.25/1, STI/trypsin weight ratio) and saturating
(1/1) concentrations and the formation of the 43 kDa inhib-
itory complex was followed in SDS-PAGE. At weight ratios
with trypsin ranging from 0.25 to 1.0, STI caused a rapid,
dose-dependent inhibition of trypsin, consistent with the
known standard mechanism of action of this serine proteinase
inhibitor [19] (data not shown). Thus, the maximal inhibitions
of trypsin expected to occur at each STI concentration were
observed just after the addition of the inhibitor and did not
change after incubation for 2.5 h at 37‡C. In separate experi-
ments, it was also veri¢ed that neither PBN nor heparin alone
interacted with STI.
STI at a 0.25/1 weight ratio with trypsin caused a
mean þ S.D. enzyme inhibition of 38.8% þ 5.8 (n = 6). The ad-
dition of PBN increased the enzyme inhibition by a value
equivalent to the inhibition produced by PBN alone. This
result indicates that PBN binds to free catalytic sites on tryp-
sin without interfering with STI binding. The £uorescence
emission spectra and SDS-PAGE of STI with heparin con-
¢rmed that there was no interaction between these two sub-
stances. Also, incubation of STI with heparin for 2.5 h at
37‡C did not alter the inhibitory capacity of STI either
(data not shown). Thus, any modi¢cation of trypsin seen after
the addition of heparin and PBN in the presence of STI would
be expected to be due to the interaction of heparin and PBN
with trypsin only. The e¡ects of PBN together with heparin at
both saturating and non-saturating concentrations of STI
were evaluated by means of SDS- and non-denaturing electro-
phoresis, since the signi¢cant absorbance of PBN even at the
wavelengths of 350^320 nm prevented any spectroscopic anal-
ysis of structural modi¢cations of trypsin. Densitometric anal-
ysis of the band of the trypsin-STI complex at low STI con-
centrations showed that it was more intense in the presence of
PBN than in its absence (Fig. 4, lane 3 versus lane 1), con-
sistent with data on the amidolytic activity of trypsin showing
that PBN has an additive e¡ect on inhibition by STI. When
the STI/trypsin complex was maximal (i.e. at a 1/1 ratio:
activity inhibition of 96%), the addition of PBN with heparin
at both concentrations no longer caused the fragmentation of
trypsin seen in the absence of STI (lanes 4 and 6 in Fig. 2A
versus lanes 6 and 8 in Fig. 4). At non-saturating STI con-
centrations, which may still allow heparin to bind to free sites
on trypsin, the trypsin bands still had a slightly higher mo-
bility and staining was more di¡use in the low molecular mass
region, consistent with the occurrence of limited damage to
the enzyme structure (Fig. 4, lanes 5 and 7). Thus, heparin
binding to the catalytic site of trypsin is necessary in order for
heparin to cause enzyme fragmentation sustained by the gen-
eration of radicals. The EPR spectra of trypsin with heparin
in the presence of STI (at any concentration) con¢rmed that
signals indicating radical formation could no longer be de-
tected (data not shown).
In order to verify whether the carbon atom of the PBN
molecule was involved in binding to trypsin, the CD spectra
of trypsin with PBN were performed in the wavelength region
beyond that of absorbance of amino acid residues. The result-
Fig. 2. SDS- and non-denaturing PAGEs of trypsin in the absence
and presence of heparin with and without PBN after incubation for
2.5 h at 37‡C. Lanes in (A) (SDS-PAGE) and (B) (non-denaturing
electrophoresis) are 1, trypsin; 2, with PBN; 3 and 4, with 36 Wg/ml
heparin, without and with PBN; 5 and 6, with 360 Wg/ml heparin,
without and with PBN. (B) Cathode at the top.
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ing signal did not di¡er at all from control signals, thus negat-
ing the possibility that the carbon became chiral because of its
binding to the proteinase.
4. Concluding remarks
The results of this work reveal an unexpected, apparently
paradoxical e¡ect of PBN, capable to enhance the heparin-
catalyzed oxidative degradation of trypsin. This e¡ect is due
to the unique property of PBN to bind irreversibly to sites on
the catalytic triad, altering the enzyme structure in such a way
that binding of heparin and the following radical production
is further increased.
The results also suggest that N-linked oxygen on the PBN
molecule is the most likely reactive site involved in binding.
The negatively charged oxygen may either take ion linkages
with the positively charged N-atom of a histidine residue
(His57) or drive a nucleophilic attack on the L-carboxyl group
of an aspartic acid residue (Asp102) of the catalytic triad in
trypsin, whereas the carbon atom of PBN would be free to
trap the radical, as expected. Thus, the e¡ect of PBN in en-
hancing radical-dependent e¡ects of heparin is independent of
the spin-trapping property, which is apparently preserved (if
this were not the case, no EPR spectra would ever been seen
with trypsin plus heparin [13]). Considering that radicals gen-
erated by heparin are mostly protein-bound [13], PBN is ex-
pected to exert its spin-trapping property only when it is
bound to trypsin, blocking radicals which form in close prox-
imity to its binding site.
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Fig. 4. SDS-PAGE of trypsin complexed with STI. E¡ects of PBN
and PBN plus heparin after incubation for 2.5 h at 37‡C. STI was
added to trypsin immediately before the addition of PBN and hepa-
rin. L, H: low and high concentrations of STI (0.25/1 and 1/1 STI/
trypsin weight ratios).
Fig. 3. Electrospray mass spectrometry analysis of trypsin incubated with PBN in absence and presence of heparin. Analysis was performed as
speci¢ed in Section 2 on 300 Wg proteins of trypsin incubated with PBN in absence (control, 1) and presence of 36 Wg/ml (2) and 360 Wg/ml
heparin (3). Spectra are presented with the corresponding molecular mass of peaks detected.
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